The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of risk factors for gastrointestinal irAEs associated with immune checkpoint inhibitors.
 
Ryo Morikawa
No Relationships to Disclose
 
Kentaro Nitta
No Relationships to Disclose
 
Shuntaro Yasuda
No Relationships to Disclose
 
Rika Noji
No Relationships to Disclose
 
Yoshihito Kano
No Relationships to Disclose
 
Shingo Sato
No Relationships to Disclose
 
Sadakatsu Ikeda
Honoraria - ACT Genomics; ACT Med; AstraZeneca; Bristol-Myers Squibb-Ono Pharmaceutical; Canon Medical System; Chugai Pharma; Guardant Health; MSD; Novartis; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Genodive pharma (Inst)
Research Funding - ACT Genomics (Inst); Canon Medical System (Inst); Hitachi (Inst)
 
Masashi Nagata
No Relationships to Disclose
 
Takehiko Mori
No Relationships to Disclose
 
Mitsukuni Suenaga
Honoraria - Bayer; Daiichi Sankyo; Lilly Japan; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda